These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38556202)

  • 21. Evaluation of the correlation between scales determining disease severity in patients with moderate-severe chronic plaque-type psoriasis.
    Gundogdu M; Kundakci N
    J Cosmet Dermatol; 2021 Jul; 20(7):2328-2331. PubMed ID: 33142051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis.
    Yu N; Peng C; Zhou J; Gu J; Xu J; Li X; Bi X; Deng H; Li X; Ding Y; Shi Y
    Br J Dermatol; 2023 Sep; 189(4):437-446. PubMed ID: 37310289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain.
    Daudén E; Vidal D; Romero A; Bordel MT; Rivera R; Márquez J; Zamora E; Martinez L; Ocaña MJ; Vila C; Iribarren P; Corona N; Zulaica A
    Actas Dermosifiliogr; 2024 Jan; 115(1):1-9. PubMed ID: 37429433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain.
    Daudén E; Vidal D; Romero A; Bordel MT; Rivera R; Márquez J; Zamora E; Martinez L; Ocaña MJ; Vila C; Iribarren P; Corona N; Zulaica A
    Actas Dermosifiliogr; 2024 Jan; 115(1):T1-T9. PubMed ID: 37923068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Salford Psoriasis Index: an holistic measure of psoriasis severity.
    Kirby B; Fortune DG; Bhushan M; Chalmers RJ; Griffiths CE
    Br J Dermatol; 2000 Apr; 142(4):728-32. PubMed ID: 10792223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China.
    Yang J; Hu K; Li X; Hu J; Tan M; Zhang M; Chen J; Kuang Y
    Clin Cosmet Investig Dermatol; 2023; 16():443-451. PubMed ID: 36815200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy.
    Al-Oudah GA; Sahib AS; Al-Hattab MK; Al-Ameedee AA
    J Popul Ther Clin Pharmacol; 2022; 29(2):e52-e60. PubMed ID: 35848197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate Psoriasis: A Proposed Definition.
    Llamas-Velasco M; de la Cueva P; Notario J; Martínez-Pilar L; Martorell A; Moreno-Ramírez D
    Actas Dermosifiliogr; 2017 Dec; 108(10):911-917. PubMed ID: 28823420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals.
    Norlin JM; Nilsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2020 Apr; 182(4):965-973. PubMed ID: 31325318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.
    Khawaja AR; Bokhari SM; Tariq R; Atif S; Muhammad H; Faisal Q; Jafferany M
    Prim Care Companion CNS Disord; 2015; 17(3):. PubMed ID: 26644955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
    Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
    Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
    Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
    Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Family History and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study from China.
    Jiang F; Lu L; Wang S; Yuan F; Cao L; Xu S; Lin B
    Clin Cosmet Investig Dermatol; 2024; 17():891-900. PubMed ID: 38660588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool.
    Leonardi C; See K; Gallo G; McKean-Matthews M; Zhang Y; Goldblum O; Mallbris L; Burge R
    Dermatol Ther (Heidelb); 2021 Aug; 11(4):1249-1263. PubMed ID: 34047947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.
    Golbari NM; van der Walt JM; Blauvelt A; Ryan C; van de Kerkhof P; Kimball AB
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):417-421. PubMed ID: 32978847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
    Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
    Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.